Related Articles
Luteolin decreases atherosclerosis in LDL receptor‑deficient mice via a mechanism including decreasing AMPK‑SIRT1 signaling in macrophages
Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice
Experimental study of the anti-atherosclerotic effect of demethylzeylasteral
Sicyos angulatus ameliorates atherosclerosis through downregulation of aortic inflammatory responses in apolipoprotein E‑deficient mice
MicroRNA‑133b aggravates atherosclerosis by activating the Notch signaling pathway